Page last updated: 2024-10-22

amitriptyline and Dental Pulp Disease

amitriptyline has been researched along with Dental Pulp Disease in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"This report presents two cases diagnosed with atypical odontalgia (AO) and successfully treated with amitriptyline as well as providing a review of the current literature on the subject."4.84Diagnosis and treatment of atypical odontalgia: a review of the literature and two case reports. ( Melis, M; Secci, S, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melis, M1
Secci, S1

Reviews

1 review available for amitriptyline and Dental Pulp Disease

ArticleYear
Diagnosis and treatment of atypical odontalgia: a review of the literature and two case reports.
    The journal of contemporary dental practice, 2007, Mar-01, Volume: 8, Issue:3

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Dental Pulp Diseases; Diagnosis, Differentia

2007